Actively Recruiting
Intestinal Metaplasia Cohort for Gastric Cancer Prediction
Led by Seoul National University Hospital · Updated on 2024-11-29
1000
Participants Needed
1
Research Sites
511 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, we aim to establish a prospective cohort of patients with endoscopically and histologically confirmed intestinal metaplasia, collect gastric mucosal tissue samples from this cohort, and follow the development of gastric cancer over time.
CONDITIONS
Official Title
Intestinal Metaplasia Cohort for Gastric Cancer Prediction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who visit Seoul National University Hospital
- Patients who have been visually diagnosed with intestinal metaplasia at a prior exam
You will not qualify if you...
- Patients who have been previously diagnosed with gastric cancer or adenoma
- Patients who have previously received gastrectomy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, South Korea
Actively Recruiting
Research Team
S
Soo-Jeong Cho, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here